Wendall Wierenga, Director at CYTOKINETICS INC (CYTK), sold 4,452 shares at $52.25 ($233K) on 2024-10-28, disclosed to the SEC on 2024-10-31.
Scheduled sale ($233k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |
| CYTK | SELL | 2023-08-21 | $386K | — | Filing → |